Health Affairs, 27, no. 6 (2008): 1612-1615 doi: 10.1377/hlthaff.27.6.1612 © 2008 by Project HOPE	New Online   House Health Reform Bill   Paying for Reform   Vetting AHIP's Report   HIV/AIDS Costs   Brief: Insurance Reform   HA Blog Top 10

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hudson, K. Search for Related Content PubMed PubMed Citation Articles by Hudson, K. Related Collections Research And Technology Health Spending Evidence-Based Medicine

Perspectives

PERSPECTIVE

The Health Benefits Of Genomics: Out With The Old, In With The New

The disproportionate emphasis on discovery research in genetics and genomics needs to be balanced by new approaches to funding translational research, development of evidence-based clinical guidelines, and robust regulation of genetic tests. These measures will help ensure that patients, providers, and others are better able to discriminate between valid genomic applications that can improve public health and those that are not useful and potentially harmful. Doing so will require that we dispense with models of research support and regulatory guidance designed for the pre–Human Genome Project world, and replace them with policies and programs as innovative as genetics research itself has been.

                      What's this?

This article has been cited by other articles:

				M. J. Khoury Evidence Dilemma: The Authors Respond Health Aff., May 1, 2009; 28(3): 926 - 927. [Full Text] [PDF]